BROKERS CHOICE: KIMS, MAXHEALTH, SONABLW, SUZLON, TATACAPITAL, BIOCON, INDIGO

AHMEDABAD, 8 DECEMBER: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

GS on KIMS: Initiate Buy on Company, target price at Rs 900/Sh (Positive)

GS on Max Health: Initiate Buy on Company, target price at Rs 1325/Sh (Positive)

Nuvama on Sona BLW: Maintain Buy on Company, target price at Rs 750/Sh (Positive)

MS on Suzlon: Maintain Overweight on Company, target price at Rs 78/Sh (Positive)

Kotak on Tata Capital: Initiate Add on Company, target price at Rs 360/Sh (Positive)

MS on Bajaj Finance: Maintain Overweight on Company, target price at Rs 1195/Sh (Positive)

Emkay on Fino Payment Bank: Maintain Add on Company, raise target price at Rs 330/Sh (Positive)

Avendus on Biocon: Maintain Add on Company, target price at Rs 435/Sh (Positive)

Citi on India Strategy: Citi says bank NIMs near cyclical trough, sees room for MCLR and deposit rate cuts, and expects ₹50,000 cr–₹1 lakh cr OMOs in 4QFY26; prefers AU SFB, RBL, SBI and BoB (Positive)

GS on India Strategy: RBI’s 25 bps rate cut to 5.25%, lower inflation forecasts and stronger growth outlook; expects limited further cuts unless US-tariff risks persist into CY26 (Neutral)

GS on Biocon: Maintain Neutral on Company, target price at Rs 375/Sh (Neutral)

Jeeferies on Indigo: Maintain Buy on Company, target price at Rs 7025/Sh (Neutral)

UBS on Indigo: Maintain Buy on Company, cut target price at Rs 6350/Sh (Neutral)

JP Morgan on Bajaj Finance: Maintain Neutral on Company, target price at Rs 1040/Sh (Neutral)

Investec on Indigo: Company must comply with the new FDTL norms by 10 February 2026. Bad just goes worse, cut target price at Rs 4040/Sh (Negative)

JM FIn on Indigo: Passing turbulence could lead to some lasting cost pressures (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)